---
schema_version: "secwatch.filing_event.v1"
accession: "0001179929-23-000021"
form_type: "8-K"
ticker: "MOH"
cik: "0001179929"
company_name: "MOLINA HEALTHCARE, INC."
filed_at: "2023-02-08T23:59:59+00:00"
generated_at: "2026-06-19T21:30:53.909880+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "medium"
source: SEC EDGAR
---

# Molina Healthcare Q4 2022 adj. EPS $4.10 vs $2.88 YoY; full-year adj. EPS $17.92 vs $13.54

## Summary
- Q4 2022 premium revenue $7.9B, up 10.5% YoY; total revenue $8.2B.
- Q4 GAAP diluted EPS $0.96, adjusted EPS $4.10; full-year GAAP EPS $13.55, adjusted $17.92.
- Medical care ratio improved to 88.3% in Q4 from 88.8% a year ago; full-year MCR 88.0%.
- After-tax margin expanded to 2.9% (adjusted) in Q4 from 2.3% in prior year.

## SEC filing metadata
- accession: 0001179929-23-000021
- form_type: 8-K
- ticker: MOH
- cik: 0001179929
- company_name: MOLINA HEALTHCARE, INC.
- filed_at: 2023-02-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1179929/000117992923000021/0001179929-23-000021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1179929/000117992923000021/moh-20230208.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001179929-23-000021
- JSON: https://secwatch.observer/filing/0001179929-23-000021.json
- Plain text: https://secwatch.observer/filing/0001179929-23-000021.txt

## Key facts
- Earnings Releases
  MOLINA HEALTHCARE, INC. updated its the fourth quarter and year ended December 31, 2022 guidance (reaffirmed).
  - Period: the fourth quarter and year ended December 31, 2022
  - Guidance: reaffirmed
  - Result: reported results
  source text: On February 8, 2023, Molina Healthcare, Inc. (the “Company”) issued a press release reporting its financial results for the fourth quarter and year ended December 31, 2022, and the Company’s full-year 2023 revenue and earnings guidance.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1179929/000117992923000021/0001179929-23-000021-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.